Cited by 87Abdominal vascular conditions and treatmentsPeripheral Artery Disease ManagementRenal and Vascular Pathologies

Reinterventions for stent restenosis in patients treated for atherosclerotic mesenteric artery disease

Open access
Tallarita, Tiziano, Oderich, Gustavo S., Macedo, Thanila A., Gloviczki, Peter, Misra, Sanjay, Duncan, Audra A., Kalra, Manju, Bower, Thomas C.·2011·Journal of Vascular Surgery

Abstract

Objective Mesenteric artery angioplasty and stenting (MAS) has been plagued by high restenosis and reintervention rates. The purpose of this study was to review the outcomes of patients treated for mesenteric artery in-stent restenosis (MAISR). Methods The clinical data of 157 patients treated for chronic mesenteric ischemia with MAS of 170 vessels was entered into a prospective database (1998-2010). Fifty-seven patients (36%) developed MAISR after a mean follow-up of 29 months, defined by duplex ultrasound peak systolic velocity >330 cm/s and angiographic stenosis >60%. We reviewed the clinical data, radiologic studies, and outcomes of patients who underwent reintervention for restenosis. End points were mortality and morbidity, patient survival, symptom recurrence, reintervention, and patency rates. Results There were 30 patients (25 female and five male; mean age, 69 ± 14 years) treated with reintervention for MAISR. Twenty-four patients presented with recurrent symptoms (21 chronic, three acute), and six had asymptomatic preocclusive lesions. Twenty-six patients (87%) underwent redo endovascular revascularization (rER) with stent placement in 17 (13 bare metal and four covered) or percutaneous transluminal angioplasty (PTA) in nine. The other four patients (13%) had open bypass, one for acute ischemia. There was one death (3%) in a patient treated with redo stenting for acute mesenteric ischemia. Seven patients (27%) treated by rER developed complications, including access site problems in four patients, and distal embolization with bowel ischemia, congestive heart failure and stent thrombosis in one each. Symptom improvement was noted in 22 of the 24 symptomatic patients (92%). After a mean follow-up of 29 ± 12 months, 15 patients (50%) developed a second restenosis, and seven (23%) required other reintervention. Rates of symptom recurrence, restenosis, and reinterventions were 0/4, 0/4, and 0/4 for covered stents, 2/9, 3/9, and 2/9 for PTA, 5/13, 8/13, and 5/13 for bare metal stents, and 1/4, 4/4, and 0/4 for open bypass. For all patients, freedom from recurrent symptoms, restenosis, and reinterventions were 70% ± 10%, 60% ± 10% and 50% ±10% at 2 years. For patients treated by rER, secondary patency rates were 72 ± 12 at the same interval. Conclusions Nearly 40% of patients developed mesenteric artery in-stent restenosis, of which half required reintervention because of symptom recurrence or progression to an asymptomatic preocclusive lesion. Mesenteric reinterventions were associated with low mortality (3%), high complication rate (27%), and excellent symptom improvement (92%).

Integrity signals

Registry

Crossref · 10.1016/j.jvs.2011.06.002

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tallarita, T., Oderich, G. S., Macedo, T. A., Gloviczki, P., Misra, S., Duncan, A. A., Kalra, M., & Bower, T. C.
Affiliations
Mayo Clinic (US)
Corresponding author
Oderich, Gustavo S.
Venue
Journal of Vascular Surgery
Publisher
Elsevier BV
Published
2011-11
Volume
54
Issue
5
Pages
1422-1429.e1
ISSN
0741-5214 (ISSN-L)
OpenAlex
W2020301331
Cited by
87
References
27
Citations by year
2026: 2 · 2025: 8 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 7 · 2020: 7 · 2019: 10 · 2018: 5 · 2017: 7 · 2016: 4 · 2015: 9 · 2014: 7 · 2013: 9 · 2012: 5
FWCI
6.83
Type
journal article
Language
en
Open access
Locations
  • Journal of Vascular Surgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal and Vascular Pathologies
Keywords
chronic mesenteric ischemia, acute mesenteric ischemia, reintervention, percutaneous transluminal angioplasty, covered stent, bare-metal stents, stent thrombosis, distal embolization, stent patency
MeSH terms
Aged, Aged, 80 and over, Constriction, Pathologic, Female, Humans, Male, Mesenteric Arteries, Mesenteric Vascular Occlusion, Middle Aged, Minnesota, Prosthesis Design, Recurrence, Retrospective Studies, Risk Factors, Time Factors, Tomography, X-Ray Computed, Vascular Patency, Stents, Survival Rate, Chi-Square Distribution, Treatment Outcome, Angioplasty, Risk Assessment, Ultrasonography, Doppler, Duplex, Retreatment, Atherosclerosis, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review